ResMed Acquires Ectosense’s NightOwl™ Home Sleep Apnea Test
October 13, 2021 |
SAN DIEGO – ResMed has completed the acquisition of Ectosense, a cloud-connected home sleep test device. Ectosense’s FDA-approved NightOwl™ is sold in the United States, Australia, New Zealand, India, and parts of Europe. ResMed has distributed NightOwl in Australia, New …
